Haidopoulos D - Search Results

1

Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13,800 patients and 23,340 controls in 19 observational studies.

Psaltopoulou T, Kosti RI, Haidopoulos D, Dimopoulos M, Panagiotakos DB. Psaltopoulou T, et al. Among authors: haidopoulos d. Lipids Health Dis. 2011 Jul 30;10:127. doi: 10.1186/1476-511X-10-127. Lipids Health Dis. 2011. PMID: 21801436 Free PMC article. Review.

2

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy.

Bamias A, Psaltopoulou T, Sotiropoulou M, Haidopoulos D, Lianos E, Bournakis E, Papadimitriou C, Rodolakis A, Vlahos G, Dimopoulos MA. Bamias A, et al. Among authors: haidopoulos d. Cancer. 2010 Mar 15;116(6):1462-8. doi: 10.1002/cncr.24915. Cancer. 2010. PMID: 20108307 Free article.

3

VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2.

Ziogas AC, Gavalas NG, Tsiatas M, Tsitsilonis O, Politi E, Terpos E, Rodolakis A, Vlahos G, Thomakos N, Haidopoulos D, Antsaklis A, Dimopoulos MA, Bamias A. Ziogas AC, et al. Among authors: haidopoulos d. Int J Cancer. 2012 Feb 15;130(4):857-64. doi: 10.1002/ijc.26094. Epub 2011 May 25. Int J Cancer. 2012. PMID: 21445972

4

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.

Bamias A, Karadimou A, Soupos N, Sotiropoulou M, Zagouri F, Haidopoulos D, Thomakos N, Rodolakis A, Antsaklis A, Dimopoulos MA. Bamias A, et al. Among authors: haidopoulos d. Gynecol Oncol. 2011 Oct;123(1):37-42. doi: 10.1016/j.ygyno.2011.06.033. Epub 2011 Jul 18. Gynecol Oncol. 2011. PMID: 21764430

5

Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor.

Bamias A, Sotiropoulou M, Zagouri F, Trachana P, Sakellariou K, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A, Dimopoulos MA. Bamias A, et al. Among authors: haidopoulos d. Eur J Cancer. 2012 Jul;48(10):1476-83. doi: 10.1016/j.ejca.2011.09.023. Epub 2011 Oct 31. Eur J Cancer. 2012. PMID: 22047635

6

A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcome.

Bamias A, Bamia C, Karadimou A, Soupos N, Zagouri F, Rodolakis A, Haidopoulos D, Vlahos G, Thomakos N, Antsaklis A, Dimopoulos MA. Bamias A, et al. Among authors: haidopoulos d. Oncology. 2011;81(5-6):365-71. doi: 10.1159/000334230. Epub 2012 Jan 13. Oncology. 2011. PMID: 22248920

7

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2.

Gavalas NG, Tsiatas M, Tsitsilonis O, Politi E, Ioannou K, Ziogas AC, Rodolakis A, Vlahos G, Thomakos N, Haidopoulos D, Terpos E, Antsaklis A, Dimopoulos MA, Bamias A. Gavalas NG, et al. Among authors: haidopoulos d. Br J Cancer. 2012 Nov 20;107(11):1869-75. doi: 10.1038/bjc.2012.468. Br J Cancer. 2012. PMID: 23169339 Free PMC article.

8

Management of uterine sarcomas and prognostic indicators: real world data from a single-institution.

Kyriazoglou A, Liontos M, Ziogas DC, Zagouri F, Koutsoukos K, Tsironis G, Tsiara A, Kaparelou M, Zakopoulou R, Thomakos N, Haidopoulos D, Papaspyrou I, Rodolakis A, Bamias A, Dimopoulos MA. Kyriazoglou A, et al. Among authors: haidopoulos d. BMC Cancer. 2018 Dec 13;18(1):1247. doi: 10.1186/s12885-018-5156-1. BMC Cancer. 2018. PMID: 30541504 Free PMC article.

9

Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysis.

Zagouri F, Korakiti AM, Zakopoulou R, Kyriazoglou A, Zografos E, Haidopoulos D, Apostolidou K, Papatheodoridi MA, Dimopoulos MA. Zagouri F, et al. Among authors: haidopoulos d. Cancer Treat Rev. 2019 Sep;79:101885. doi: 10.1016/j.ctrv.2019.08.001. Epub 2019 Aug 6. Cancer Treat Rev. 2019. PMID: 31442939

10

JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer.

Bagratuni T, Mavrianou N, Gavalas NG, Tzannis K, Arapinis C, Liontos M, Christodoulou MI, Thomakos N, Haidopoulos D, Rodolakis A, Kastritis E, Scorilas A, Dimopoulos MA, Bamias A. Bagratuni T, et al. Among authors: haidopoulos d. Eur J Cancer. 2020 Feb;126:125-135. doi: 10.1016/j.ejca.2019.11.017. Epub 2020 Jan 9. Eur J Cancer. 2020. PMID: 31927213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters